Sanofi to pay more than $25 million to resolve corruption charges - SEC

WASHINGTON (Reuters) - French pharmaceutical giant Sanofi <SASY.PA> will pay more than $25 million (19.47 million pounds) to settle charges that its Kazakhstan and Middle East subsidiaries made corrupt payments to win business, the top U.S. securities regulator said on Tuesday.

Without admitting or denying the findings, the company agreed to pay $17.5 million in disgorgement, $2.7 million in prejudgement interest and a civil penalty of $5 million, the Securities and Exchange Commission said.

(Reporting by Lisa Lambert; Editing by Chizu Nomiyama)